Shares in UK company Indivior jumped by more than 12% on Aug. 17 on the LSE on the back of top-line Phase III data for its monthly buprenorphine depot for opioid addiction, and confirmation that a Q4 2017 US approval is still within its sights.

China’s largest pharmaceutical distributor has built up a web of subsidiaries to expand its manufacturing and distribution capabilities. The company said global pharma companies may need to change their sales models in China as a result of corruption probes and it wants to be first in line to help.

Profile of Penn's tech transfer office and its push to generate start-ups.

Physicians are joining together under unified management structures to become more efficient, able competitors in an increasingly capitated world. Efforts are farthest along in the lucrative and growing market for cancer treatment, but specialty physician groups of all kinds are moving to stake turf and sell their services to managed care. Information technology will be key to balancing quality and cost--and proving it.